MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
about
Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersMucin-based targeted pancreatic cancer therapyConcomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cellsElimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme CellsPathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progeniesNovel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.A concise review on the current understanding of pancreatic cancer stem cellsNicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer.Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.Emerging role of mucins in epithelial to mesenchymal transition.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signalingCell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas.Membrane drug transporters and chemoresistance in human pancreatic carcinoma.Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer.Mucins and pancreatic cancer.Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer.MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy.Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survivalDiagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinomaMicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines.Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens-Tumor Metastasis by Migration?Molecular Pathways: Mucins and Drug Delivery in Cancer.Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine.Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways
P2860
Q26822406-37F88CCB-AA97-4DA0-8FAA-9DCD8CD64965Q26861761-CCD28C59-FA3F-4028-BF69-AD0F56364743Q28533295-44F9E44F-C916-4EDD-83F3-170F94124DE3Q30048454-73A57F00-9516-4C06-B771-E1877D31BED5Q31049380-9DB75FBF-7CF3-4D79-89FF-0B37D47E7C30Q34382586-0732364C-D6BA-4D18-8D3C-E1547D75DD88Q34500864-C19AA010-D6AC-4D8B-8D43-245B8F418FC4Q34585874-38926E4A-55B5-441C-AE3F-96A6368EA2BCQ35749993-8E3D12EE-8A83-4B25-BDD6-29390BD28EF7Q35801362-48D19B0F-6C58-4E92-8553-5F5F8B2C48FCQ36188223-9A561550-3662-4333-A145-961C01D5689DQ36746688-2A375156-F22D-4E30-87BE-275AF9E3D71DQ36994566-B8C997F0-EDE8-4579-A6A3-433FBE8D6453Q37302883-6F8F4E95-FCF3-40AA-829A-B152D440B313Q37584296-D76C531E-E9C7-4695-B1D3-F64A014C0615Q37610799-E2F3B3A8-40E3-425C-B047-63A509C40CFAQ37641751-DA20E522-5492-4EF7-9B66-1994EF7B6BB3Q37705843-DEFCE15A-5475-4CE2-B676-D9589761C050Q37706759-D42CBB49-9B41-4252-92FD-CD4A9CE2F0C7Q38161328-673392BA-3EBE-486C-A9D1-39B4E4E9AE81Q38161340-68BD5ADD-299A-4432-894D-510CBDC15676Q38166583-4F064083-1892-4C28-B6E8-C46905607846Q38221692-CC0122A7-31FD-4A51-BFAB-9A6B3BADE17FQ38688917-2A33F48E-C795-427D-A850-56AEB3E3FEC0Q38804960-CC528605-BF8C-4D8B-86D9-AE75A53897D4Q39410445-DF40BE96-D41F-4016-A9F7-BB2094C7440BQ41576862-5998C8E6-BBD4-4750-A0C7-46A99C42A711Q42245576-BC9A902B-BC22-4119-97F6-009740DBBD58Q42554135-A31F8F2D-6B03-4EC2-934F-4324E3D48BB4Q48265598-5DF5DE4C-541C-46F0-8BDC-6A81690A0433Q50465411-C302736F-5D66-4C8B-ABCD-005B2CE6146EQ51107700-2686C904-D62E-4815-8E84-BCC7EB76E609Q55639950-A0D7087A-35F3-424D-90F8-B1468D4A4AAAQ58695612-3EB23E5B-C8D6-4771-918C-69C45A05005C
P2860
MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
MUC4 down-regulation reverses ...... itor cells and their progenies
@ast
MUC4 down-regulation reverses ...... itor cells and their progenies
@en
type
label
MUC4 down-regulation reverses ...... itor cells and their progenies
@ast
MUC4 down-regulation reverses ...... itor cells and their progenies
@en
prefLabel
MUC4 down-regulation reverses ...... itor cells and their progenies
@ast
MUC4 down-regulation reverses ...... itor cells and their progenies
@en
P2093
P2860
P1433
P1476
MUC4 down-regulation reverses ...... itor cells and their progenies
@en
P2093
Murielle Mimeault
Navneet Momi
Shantibhusan Senapati
Sonny L Johansson
Subhankar Chakraborty
Surinder K Batra
P2860
P356
10.1016/J.CANLET.2010.02.015
P407
P577
2010-03-19T00:00:00Z